Pashayan N - Search Results

1

Polygenic susceptibility to prostate and breast cancer: implications for personalised screening.

Pashayan N, Duffy SW, Chowdhury S, Dent T, Burton H, Neal DE, Easton DF, Eeles R, Pharoah P. Pashayan N, et al. Br J Cancer. 2011 May 10;104(10):1656-63. doi: 10.1038/bjc.2011.118. Epub 2011 Apr 5. Br J Cancer. 2011. PMID: 21468051 Free PMC article.

2

DNA methylation at quantitative trait loci (mQTLs) varies with cell type and nonheritable factors and may improve breast cancer risk assessment.

Herzog C, Jones A, Evans I, Zikan M, Cibula D, Harbeck N, Colombo N, Rådestad AF, Gemzell-Danielsson K, Pashayan N, Widschwendter M. Herzog C, et al. Among authors: pashayan n. NPJ Precis Oncol. 2023 Sep 27;7(1):99. doi: 10.1038/s41698-023-00452-2. NPJ Precis Oncol. 2023. PMID: 37758816 Free PMC article.

3

Incidence trends of prostate cancer in East Anglia, before and during the era of PSA diagnostic testing.

Pashayan N, Powles J, Brown C, Duffy SW. Pashayan N, et al. Br J Cancer. 2006 Aug 7;95(3):398-400. doi: 10.1038/sj.bjc.6603247. Epub 2006 Jul 11. Br J Cancer. 2006. PMID: 16832416 Free PMC article.

4

Excess cases of prostate cancer and estimated overdiagnosis associated with PSA testing in East Anglia.

Pashayan N, Powles J, Brown C, Duffy SW. Pashayan N, et al. Br J Cancer. 2006 Aug 7;95(3):401-5. doi: 10.1038/sj.bjc.6603246. Epub 2006 Jul 11. Br J Cancer. 2006. PMID: 16832417 Free PMC article.

5

Survival trends for small intestinal cancer in England and Wales, 1971-1990: national population-based study.

Pashayan N, Lepage C, Rachet B, Woods LM, Coleman MP. Pashayan N, et al. Br J Cancer. 2006 Nov 6;95(9):1296-300. doi: 10.1038/sj.bjc.6603417. Epub 2006 Oct 10. Br J Cancer. 2006. PMID: 17031398 Free PMC article.

6

Avoiding bias from aggregate measures of exposure.

Duffy SW, Jonsson H, Agbaje OF, Pashayan N, Gabe R. Duffy SW, et al. Among authors: pashayan n. J Epidemiol Community Health. 2007 May;61(5):461-3. doi: 10.1136/jech.2006.050203. J Epidemiol Community Health. 2007. PMID: 17435216 Free PMC article.

7

Mean sojourn time, overdiagnosis, and reduction in advanced stage prostate cancer due to screening with PSA: implications of sojourn time on screening.

Pashayan N, Duffy SW, Pharoah P, Greenberg D, Donovan J, Martin RM, Hamdy F, Neal DE. Pashayan N, et al. Br J Cancer. 2009 Apr 7;100(7):1198-204. doi: 10.1038/sj.bjc.6604973. Epub 2009 Mar 17. Br J Cancer. 2009. PMID: 19293796 Free PMC article.

8

Stage shift in PSA-detected prostate cancers - effect modification by Gleason score.

Pashayan N, Pharoah P, Neal DE, Hamdy F, Donovan J, Martin RM, Greenberg D, Duffy SW. Pashayan N, et al. J Med Screen. 2009;16(2):98-101. doi: 10.1258/jms.2009.009037. J Med Screen. 2009. PMID: 19564523 Free PMC article. Clinical Trial.

9

Age-period-cohort analysis of colorectal cancer in East Anglia, 1971-2005.

Wessler JD, Pashayan N, Greenberg DC, Duffy SW. Wessler JD, et al. Among authors: pashayan n. Cancer Epidemiol. 2010 Jun;34(3):232-7. doi: 10.1016/j.canep.2010.03.012. Epub 2010 Apr 18. Cancer Epidemiol. 2010. PMID: 20400385

10

PSA-detected prostate cancer and the potential for dedifferentiation--estimating the proportion capable of progression.

Pashayan N, Pharoah P, Neal DE, Hamdy F, Donovan J, Martin RM, Greenberg D, Duffy SW. Pashayan N, et al. Int J Cancer. 2011 Mar 15;128(6):1462-70. doi: 10.1002/ijc.25471. Int J Cancer. 2011. PMID: 20499312 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

177 results

Search Page

Filters